Recent studies have identified CD44+EpCAMhigh cells as the tumor cell populations harboring CSC properties (self-renewal and aberrant differentiation) in CRC, which drive tumorigenic events [16, 51, 52]. This evidence concerns the gene CD44 and neoplasm.